相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC)
Ce Li et al.
FRONTIERS IN PHYSIOLOGY (2019)
Discovering Cancer Subtypes via an Accurate Fusion Strategy on Multiple Profile Data
Limin Jiang et al.
FRONTIERS IN GENETICS (2019)
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Michael Orth et al.
RADIATION ONCOLOGY (2019)
Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
Caroline Y. K. Fong et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Signaling Pathways Driving Aberrant Splicing in Cancer Cells
Vania Goncalves et al.
GENES (2018)
Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway
Rahat Jahan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Molecular Subtypes and Local-Regional Control of Breast Cancer
Simona Maria Fragomeni et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Clinical significance of MUC13 in pancreatic ductal adenocarcinoma
Sheema Khan et al.
HPB (2018)
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges
Alex Root et al.
CANCERS (2018)
Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens
Luisa Escobar Hoyos et al.
CANCER CELL (2018)
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas
Nicolas Jonckheere et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma
Shailendra K. Gautam et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
The role of RNA alternative splicing in regulating cancer metabolism
Itamar Kozlovski et al.
HUMAN GENETICS (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
Li Liu et al.
CELL DEATH & DISEASE (2017)
Impact of Alternative Splicing on the Human Proteome
Yansheng Liu et al.
CELL REPORTS (2017)
The Functional Impact of Alternative Splicing in Cancer
Hector Climente-Gonzalez et al.
CELL REPORTS (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer
Lakshmi Reddy Bollu et al.
CLINICAL CANCER RESEARCH (2017)
Membrane-Tethered MUC1 Mucin Counter-Regulates the Phagocytic Activity of Macrophages
Kosuke Kato et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Alternative splicing and cell survival: from tissue homeostasis to disease
Maria Paola Paronetto et al.
CELL DEATH AND DIFFERENTIATION (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Md Kamal Hossain et al.
VACCINES (2016)
The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways
Romain Vasseur et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Targeting FGFR Signaling in Cancer
Mehdi Touat et al.
CLINICAL CANCER RESEARCH (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Symptoms of Pancreatic Cancer in Primary Care
Mia Schmidt-Hansen et al.
PANCREAS (2015)
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Eun Sun Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
p53 in breast cancer subtypes and new insights into response to chemotherapy
Philippe Bertheau et al.
BREAST (2013)
Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer
Neeley Remmers et al.
CLINICAL CANCER RESEARCH (2013)
Mucins in pancreatic cancer and its microenvironment
Sukhwinder Kaur et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
N. Skrypek et al.
ONCOGENE (2013)
Human housekeeping genes, revisited
Eli Eisenberg et al.
TRENDS IN GENETICS (2013)
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
Satyanarayana Rachagani et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
S. Senapati et al.
ONCOGENE (2012)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Precursor lesions in pancreatic cancer: morphological and molecular pathology
Christopher J. Scarlett et al.
PATHOLOGY (2011)
International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data
Junjun Zhang et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2011)
Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
Qicheng Zhao et al.
MOLECULAR CANCER (2010)
Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
S. Bafna et al.
BRITISH JOURNAL OF CANCER (2009)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Mo Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Structure, evolution, anal biology of the MUC4 mucin
Pallavi Chaturvedi et al.
FASEB JOURNAL (2008)
Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans
N Moniaux et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer
Y Hamanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
分享论文
